Poor dental condition
(UMLS:C1168170)
- UMLS ID:
- C1168170
- MeSH ID:
- N/A
Synonym(s)
1.
Poor dental condition
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Zoledronic Acid | FAERS: 6 | OFFSIDES US FAERS | |
| 2 | HhAntag691 | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | Ibandronic Acid | FAERS: 4 | OFFSIDES US FAERS | |
| 4 | Rivaroxaban | FAERS: 3 | US FAERS | |
| 5 | Clozapine | FAERS: 2 | US FAERS | |
| 6 | Dronedarone | FAERS: 2 | US FAERS | |
| 7 | Teriparatide | FAERS: 2 | US FAERS | |
| 8 | Deferasirox | FAERS: 1 | US FAERS | |
| 9 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Lisinopril | FAERS: 1 | US FAERS | |
| 11 | Methamphetamine | FAERS: 1 | US FAERS | |
| 12 | Norgestrel | FAERS: 1 | US FAERS | |
| 13 | Olanzapine | FAERS: 1 | US FAERS | |
| 14 | Pamidronate | FAERS: 1 | US FAERS | |
| 15 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 16 | Raloxifene Hydrochloride | FAERS: 1 | US FAERS | |
| 17 | Risperidone | FAERS: 1 | US FAERS | |
| 18 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 19 | Valproic Acid | FAERS: 1 | US FAERS | |
| 20 | cabozantinib | FAERS: 1 | US FAERS | |
| 21 | ponatinib | FAERS: 1 | US FAERS | |
| 22 | sapropterin | FAERS: 1 | US FAERS | |
| 23 | tofacitinib | FAERS: 1 | US FAERS | |
| 24 | Allopurinol | OFFSIDES | ||
| 25 | Amantadine | OFFSIDES | ||
| 26 | Anastrozole | OFFSIDES | ||
| 27 | Atovaquone | OFFSIDES | ||
| 28 | Benztropine | OFFSIDES | ||
| 29 | Bortezomib | OFFSIDES | ||
| 30 | Bupropion | OFFSIDES | ||
| 31 | Calcium Citrate | OFFSIDES | ||
| 32 | Capecitabine | OFFSIDES | ||
| 33 | Carvedilol | OFFSIDES | ||
| 34 | Cefdinir | OFFSIDES | ||
| 35 | Cefoxitin | OFFSIDES | ||
| 36 | Ceftriaxone | OFFSIDES | ||
| 37 | Chlorhexidine | OFFSIDES | ||
| 38 | Ciprofloxacin | OFFSIDES | ||
| 39 | Cisapride | OFFSIDES | ||
| 40 | Clindamycin | OFFSIDES | ||
| 41 | Cortisone | OFFSIDES | ||
| 42 | Cortisone | OFFSIDES | ||
| 43 | Diphenoxylate | OFFSIDES | ||
| 44 | Doxepin | OFFSIDES | ||
| 45 | Econazole | OFFSIDES | ||
| 46 | Epinephrine | OFFSIDES | ||
| 47 | Ertapenem | OFFSIDES | ||
| 48 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 49 | Famotidine | OFFSIDES | ||
| 50 | Fludrocortisone | OFFSIDES | ||
| 51 | Fulvestrant | OFFSIDES | ||
| 52 | Goserelin | OFFSIDES | ||
| 53 | Indapamide | OFFSIDES | ||
| 54 | Isradipine | OFFSIDES | ||
| 55 | Ketoconazole | OFFSIDES | ||
| 56 | Ketorolac | OFFSIDES | ||
| 57 | Ketorolac Tromethamine | OFFSIDES | ||
| 58 | Lenalidomide | OFFSIDES | ||
| 59 | Letrozole | OFFSIDES | ||
| 60 | Linezolid | OFFSIDES | ||
| 61 | Meperidine | OFFSIDES | ||
| 62 | Mesalamine | OFFSIDES | ||
| 63 | Methotrexate | OFFSIDES | ||
| 64 | Modafinil | OFFSIDES | ||
| 65 | Moxifloxacin | OFFSIDES | ||
| 66 | Naloxone | OFFSIDES | ||
| 67 | Omeprazole | OFFSIDES | ||
| 68 | Pamidronate | OFFSIDES | ||
| 69 | Penicillin V | OFFSIDES | ||
| 70 | Penicillins | OFFSIDES | ||
| 71 | Pilocarpine | OFFSIDES | ||
| 72 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 73 | Pravastatin | OFFSIDES | ||
| 74 | Pregabalin | OFFSIDES | ||
| 75 | Raloxifene Hydrochloride | OFFSIDES | ||
| 76 | Scopolamine | OFFSIDES | ||
| 77 | Sulbactam | OFFSIDES | ||
| 78 | Tamoxifen | OFFSIDES | ||
| 79 | Tiagabine | OFFSIDES | ||
| 80 | Varenicline | OFFSIDES | ||
| 81 | Zolpidem | OFFSIDES | ||
| 82 | anagrelide | OFFSIDES | ||
| 83 | bicalutamide | OFFSIDES | ||
| 84 | carbidopa, levodopa drug combination | OFFSIDES | ||
| 85 | cefuroxime axetil | OFFSIDES | ||
| 86 | chlorhexidine gluconate | OFFSIDES | ||
| 87 | doxifluridine | OFFSIDES | ||
| 88 | exemestane | OFFSIDES | ||
| 89 | tegaserod | OFFSIDES | ||
| 90 | telithromycin | OFFSIDES | ||
| 91 | valdecoxib | OFFSIDES | ||
| 92 | zafirlukast | OFFSIDES | ||
| 93 | zopiclone | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.